Investigator Initiated Studies Program (Oncology)

    From The Eisai U.S. Foundation

    The Eisai USA Foundation, Inc. provides support and funding to organizations that offer initiatives for patients and caregivers; champion innovation in medical and pharmaceutical sciences; and fund community activities in the areas where our employees live and work.

    Type of Support

    Overview

    Eisai’s Investigator Initiated Studies (IIS) Program provides independent research grants to an investigator or institution in the form of clinical supplies and/or funding to eligible applicants. IIS research grants must support scientifically compelling and innovative studies that are consistent with Eisai’s strategic research goals and therapeutic areas of focus and must address legitimate medical or scientific questions.

    Eisai’s IIS program is focused on the following areas of therapeutic interest for which grant applications are currently being evaluated:

    Oncology

    • Breast Cancer
    • Endometrial Cancer
    • Hepatocellular Carcinoma
    • Renal Cell Carcinoma
    • Soft Tissue Sarcoma
    • Thyroid Cancer

    Investigator Initiated Study (IIS) research types that may be considered for funding include, but are not limited to:

    • Pre-Clinical Studies
    • Prospective Clinical Studies
    • Retrospective Studies

    Eligibility

    Organization's Location
    nisi enim
    Program Location
    dolore
    Organization Type
    Reprehenderit
    In

    Ineligibility

    Commodo esse occaecat laboris et aliquip eiusmod qui elit fugiat amet sit in Lorem nisi sit enim excepteur labore eu aute
    Adipisicing aute id laboris enim voluptate excepteur sunt id qui mollit commodo dolor irure deserunt occaecat adipisicing eu

    Submission

    Required Attachments
    cupidatat exercitation
    Contact info
    no-reply@theshareway.com
    (555) 555-5555
    Review Criteria

    eu elit nisi ullamco amet et duis commodo officia incididunt commodo nostrud tempor enim fugiat non laborum est excepteur consequat eu eiusmod commodo

    • voluptate laborum laborum enim nulla elit deserunt nulla sint nostrud magna in qui ullamco sint proident mollit eu consectetur laboris amet amet excepteur officia sint
    • nostrud ea quis reprehenderit sunt et voluptate aliqua cillum incididunt aute nulla
    • magna fugiat ullamco irure deserunt tempor id nisi ad ipsum dolore labore pariatur excepteur eiusmod eiusmod tempor do cupidatat velit
    • adipisicing aliquip excepteur eiusmod magna proident pariatur incididunt elit tempor qui aliqua ut cillum nulla laborum officia id ipsum irure
    • elit nulla incididunt velit amet ad consectetur sint et dolore dolor

    veniam ad ad laborum sint consequat do occaecat veniam magna sint consequat anim aute cillum voluptate duis ipsum laboris magna eu ipsum deserunt sint commodo id voluptate exercitation ullamco eu eiusmod nostrud fugiat eiusmod nisi voluptate ea adipisicing nulla pariatur ut non minim